Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6AEA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $138,458
Award facts
- Contract value 100% obligated
- $138,458.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $138,458.04 on August 25, 2025, for the supply of Entyvio 300 mg vials. This delivery order, issued without a set-aside designation, falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The ultimate completion date for this delivery order is September 16, 2025, with performance occurring at the vendor's Park Ridge, Illinois location.
As a primary pharmaceutical supplier to the Department of Defense through the Defense Logistics Agency's SPE2DB program, DMS Pharmaceutical Group maintains a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities nationwide. Entyvio, a biologic medication used in treating inflammatory bowel diseases, represents one component of the company's extensive pharmaceutical distribution capabilities. This contract award reflects the company's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively in government procurement markets while meeting the medical supply requirements of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DX25F6AEA?
SPE2DX25F6AEA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6AEA worth?
The government has obligated $138,458 on SPE2DX25F6AEA.
Is contract SPE2DX25F6AEA an order under another contract?
Yes. SPE2DX25F6AEA is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEA competed?
The extent of competition for SPE2DX25F6AEA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award